Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Investigation of Some Virulence Genes of Uropathogenic Escherichia coli isolated from patients with Urinary Tract Infection in Mosul City, Iraq

Breadcrumb

  • Home
  • Investigation of Some Virulence Genes of Uropathogenic Escherichia Coli Isolated From Patients With Urinary Tract Infection In Mosul City, Iraq
  • Investigation of Some Virulence Genes of Uropathogenic Escherichia coli isolated from patients with Urinary Tract Infection in Mosul City, Iraq

Fanar Dawas Mahmood 1, Safaa Asaed Mohammed 1 and Khansaa Basem Fadhil 2, *

1 Directorate General of Education of Nineveh.

2 Northern Technical University.

Research Article

GSC Biological and Pharmaceutical Sciences, 2026, 34(03), 159-167

Article DOI: 10.30574/gscbps.2026.34.3.0105

DOI url: https://doi.org/10.30574/gscbps.2026.34.3.0105

Received on 11 February 2026; revised on 19 March 2026; accepted on 21 March 2026

Approximately 150 million people are infected (UTIs) affect up to 150 million people worldwide, and Escherichia coli (E. coli) is the leading cause of these infections globally. This study investigated the morphological, biochemical, and antibiotic susceptibility profiles of these bacteria using the VETIK2 system. The study also identified the virulence and antiviral gene profiles of E. coli strains identified in the GenBank database and discovered a new gene (FamsAh LC842012.1) that is a major cause of UTIs in patients in Mosul, Iraq.

Materials and Methods: 37 urine samples were collected from Al-Hayat International Hospital in Mosul from September 1 to November 31, 2025. Bacterial isolation was done by MacConkey, Eosin Methylene Blue (EMB) and blood agar. Confirmation was done by Gram staining, IMViC tests, catalase and urease tests, TSI (Triple Sugar Iron) agar reactions, and 16S rRNA sequencing. Antimicrobial susceptibility tests were conducted by the Vitek-2 system with 15 antibiotics. Virulence genes were detected by PCR in a reference strain registered as a new isolate (FaMsAh LC842012.1) in NCBI (National Center for Biotechnology Information).

Results: Out of 37 uropathogens, E. coli (14, 37.8%) was the most commonly identified organism. All the isolates were Gram-negative bacilli. They showed pink colonies on MacConkey agar and a metallic green sheen on EMB agar, and an IMViC profile of (++−−). Molecular identification through 16S rRNA, identified the isolates as E. coli. Most isolates showed extensive multidrug resistance (MDR Uropathogenic E. coli) among 9 of the 15 antibiotics tested, including amoxicillin-clavulanate, piperacillin-tazobactam, and several cephalosporins. However, the isolates were susceptible to the carbapenems (imipenem, meropenem) and to gentamicin, fosfomycin, nitrofurantoin and trimethoprim-sulfamethoxazole. The positive PCR revealed the presence of all virulence factors, (fimH, stx1, eae, hlyA), and then, the first hybrid UPEC/STEC/EPEC of its kind. 

Conclusions: The first emerging strain of multidrug-resistant Uropathogenic E. coli (UPEC) with the unprecedented presence of virulence genes associated with diarrheal disease was identified in Iraq. Monitoring the emerging UPEC strains in Iraq is of utmost importance.

Uropathogenic E. coli; UTIs; Virulence genes; Biochemical Tests; (UPEC); Morphology

https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2026-…

Preview Article PDF

Fanar Dawas Mahmood, Safaa Asaed Mohammed and Khansaa Basem Fadhil. Investigation of Some Virulence Genes of Uropathogenic Escherichia coli isolated from patients with Urinary Tract Infection in Mosul City, Iraq. GSC Biological and Pharmaceutical Sciences, 2026, 34(03), 159-167. Article DOI: https://doi.org/10.30574/gscbps.2026.34.3.0105.


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution